Pacira BioSciences: Q2 Earnings Insights

Pacira BioSciences PCRX reported its Q2 earnings results on Wednesday, August 3, 2022.

Here's what investors need to know about the announcement.

Pacira BioSciences missed estimated earnings by 42.05%, reporting an EPS of $0.51 versus an estimate of $0.88.

Revenue was up $33.82 million from the same period last year.

Last quarter the company missed on EPS by $0.19 which was followed by a 6.75% drop in the share price the next day.

Here's a look at Pacira BioSciences's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	0.83	0.90	0.65	0.69
EPS Actual	0.64	0.97	0.72	0.77
Revenue Estimate	159.49M	155.74M	130.38M	128.01M
Revenue Actual	157.99M	159.19M	127.72M	135.59M

To track all earnings releases for Pacira BioSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar